Cyrus Biotechnology, Inc. announced it raised $15.9 Million in an amended filing from an offering of $15.9 Million

Company

Location

About

Cyrus Biotechnology is a pre-clinical-stage biotech company combining protein design and screening to create novel biologics for serious unmet medical needs. Using this approach, we are developing an early pipeline of innovative programs in multiple indications. We are also partnering with leading biotech and pharma companies and research institutes to bring collaborative programs forward from discovery to the clinic.